Texas Rep. Jasmine Crockett Faces Scrutiny Over Undisclosed Stock Holdings in 25 Companies

Texas Democrat Congresswoman Jasmine Crockett has come under scrutiny for failing to disclose ownership of stocks in at least 25 companies during her 2022 congressional run and after taking office in 2023, despite previously disclosing these holdings as a Texas state legislator. Her portfolio includes shares in major corporations such as Amazon, Johnson & Johnson, AstraZeneca, ExxonMobil, and Aurora Cannabis, raising concerns about potential conflicts of interest given legislation she supported that could benefit these companies. Additionally, Crockett held a 20% stake in Black Diamond Investments, a firm that sought marijuana dispensary licenses in Ohio, while also representing a defendant in a fatal marijuana-related case and sponsoring pro-cannabis legislation. Records also revealed undisclosed debts totaling over $110,000, including loans connected to a Dallas home she lived in. Critics highlight the discrepancies between her state and federal financial disclosures as potentially violating transparency rules and warranting investigation. Despite these controversies, Crockett is reportedly considering a 2026 U.S. Senate run and remains a vocal progressive critic of President Donald Trump.